The UK has long been at the forefront of innovation and regulation in the cell and gene therapy sector, playing a key role in advancing this promising area of medicine for over 15 years. With ongoing support from both public and private investment, the UK continues to be a global hub for development in the field—though international competition remains strong.
This event will feature expert presentations on the current state of cell and gene therapy innovation in the UK, followed by a panel discussion focused on the strategic steps needed to ensure the UK retains its leadership position in this rapidly evolving space.
